Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.

Optimism for AI-powered drug discovery is rising as industry giants, startups, and even Sam Altman step up investments ...

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

Salesforce, Agentforce, and others are among the trademarks of Salesforce, Inc. About Viz.ai ...

AI-driven drug repurposing presents opportunities through cost-effective drug development, personalized medicine, and ...

Define Ventures’ new report provides a clear framework for how enterprise healthcare, particularly Big Pharma, is transitioning from AI exploration to execution. It focuses on core categories, ...

Artificial Intelligence (AI) is no longer confined to the tech sector; it is being aggressively integrated across all industries, from defense to food processing, with healthcare being no exception.

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

Artificial intelligence has rapidly evolved from a futuristic concept to a transformative force embedded in nearly every aspect of modern life. From voice assistants to financial forecasting to ...